Risk of Tardive Dyskinesia in Older Patients
Archives of General PsychiatryPublished 1 September 1995
Dilip V. Jeste
Citations302
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Use of higher amounts of neuroleptics, particularly high-potency ones, should be avoided in older patients, patients with alcohol abuse/dependence, or patients with a subtle movement disorder at baseline; these patients are at a higher risk of developing TD.
Abstract
Use of higher amounts of neuroleptics, particularly high-potency ones, should be avoided in older patients, patients with alcohol abuse/dependence, or patients with a subtle movement disorder at baseline; these patients are at a higher risk of developing TD.
Keywords
Medicine
Journal of Psychiatric Research“Mini-mental state”
86,858 Citations1975Marshal F. Folstein, Susan E. Folstein +1 more
A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
British Journal of Social and Clinical PsychologyDevelopment of a Rating Scale for Primary Depressive Illness
8,470 Citations1967Max Hamilton
This is an account of further work on a rating scale for depressive states, including a detailed discussion on the general problems of comparing successive samples from a ‘population’, the meaning of factor scores, and the other results obtained.
Acta Psychiatrica ScandinavicaA RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
3,263 Citations1970G. M. Simpson, M. B. +4 more
A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and reliability of the scale is presented.
Journal of Chronic DiseasesMaximum utilization of the life table method in analyzing survival
2,912 Citations1958Sidney J. Cutler, Fred Ederer
Acceptance of survival as a criterion for measuring the effectiveness of cancer therapy is attested to by the very large number of papers published every year reporting on the survival experience of cancer patients.
BiometrikaA generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
1,385 Citations1970Norman E. Breslow
American Journal of PsychiatryRisperidone in the treatment of schizophrenia
1,206 Citations1994Stephen R. Marder, Richard C. Meibach
The results indicate that the optimal daily dose of risperidone for most schizophrenic patients in this study was 6 mg; this dose was as effective as 16 mg, and the incidence of extrapyramidal symptoms in patients receiving 6 mg of ris peridone was no higher than that in Patients receiving placebo.
Annals of Internal MedicineThe Risk of Determining Risk with Multivariable Models
1,112 Citations1993John Concato, Alvan R. Feinstein +1 more
The purpose in the current research was to note the frequency with which multivariable analyses now appear in general medical journals, to identify some common problems and desirable precautions in the analyses, and to determine how well the challenges are being met.
Archives of General PsychiatryResearch Diagnoses for Tardive Dyskinesia
935 Citations1982John M. Kane
There has not yet been a systematic effort to reduce the diagnostic heterogeneity that is found within the range of patients who are identified as having tardive dyskinesia.
Archives of General PsychiatrySignificance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
550 Citations1988Ross J. Baldessarini
Assessment of immediate and later follow-up treatment of psychotic patients indicates that moderate doses are adequate for most patients, and moderate doses of neuroleptics appear, on average, to be about as effective as, and probably safer than, the larger doses that have been popular in the United States in recent years.
Archives of General PsychiatryNeuroleptic Withdrawal in Schizophrenic Patients
439 Citations1995Patricia L. Gilbert
The risk-benefit ratio of neuroleptic maintenance vs withdrawal should be assessed carefully in individual patients, and a slow taper to the lowest effective dosage may be the preferred strategy in many patients.
PsychopharmacologyA rating scale for tardive dyskinesia
390 Citations1979G. M. Simpson, J. H. Lee +2 more
A rating scale for tardive dyskinesia was developed, consisting of nearly all signs seen by two groups of investigators over a 5-year period, and has been shown to be both reliable and valid.
Biological CyberneticsTremor and other oscillations in neuromuscular systems
265 Citations1976R. B. Stein, Mehmet N. Oguztöreli
A model has been analyzed which is based on recent experimental evidence concerning the properties of muscles and the sensory feedback pathways from muscles and finds that reflex oscillations within the range 8–12 Hz found for physiological tremor and the role of longer latency reflexes in the generation of these tremors is discussed.
Schizophrenia BulletinGender Differences in Tardive Dyskinesia: A Critical Review of the Literature
263 Citations1992R. Yassa, Dilip V. Jeste
Overall, the TD prevalence seemed to reach its peak in the 50-70-year-old age group in men and continued to rise after age 70 in women, and women tended to have more severe TD than men.
Archives of General PsychiatryIdentifying Risk Factors for Tardive Dyskinesia Among Long-term Outpatients Maintained With Neuroleptic Medications
259 Citations1993Hal Morgenstern
For outpatients maintained for many years with neuroleptics, dose should be minimized to reduce the risk of TD, and this strategy does not appear to be negated by prescribing frequent changes in dosage.
Archives of NeurologyPseudoparkinsonism and Tardive Dyskinesia
220 Citations1972George E. Crane
It is shown that tardive dyskinesia is more likely to develop in patients with pseudoparkinsonian symptoms than in patients not exhibiting such manifestations.
JAMAProspective Study of Tardive Dyskinesia Incidence in the Elderly
173 Citations1991Bruce L. Saltz
Investigation of the incidence of tardive dyskinesia in elderly individuals beginning treatment with antipsychotic drugs found psychiatric (as opposed to organic) diagnosis and presence of extrapyramidal signs early in treatment were associated with increased tardiv dyskine vulnerability.
American Journal of PsychiatryFactors related to tardive dyskinesia
151 Citations1979
It was indicated that brain-damaged patients and male patients were more susceptible to severe forms of the disorder, even though these factors were not implicated in its initial appearance.
PubMedDoes clozapine cause tardive dyskinesia?
139 Citations1993John M. Kane, Margaret G. Woerner +3 more
If cases do develop, the risk of tardive dyskinesia is likely to be less with clozapine than with typical neuroleptics, and if cases do development, therisk of tARDive dysKinesia will be less than with traditional neuroleptic patients.
American Journal of PsychiatryDissimilar dosing with high-potency and low-potency neuroleptics
133 Citations1984Ross J. Baldessarini, B.A. Katz +1 more
Potent agents are commonly used in mania and schizophrenia, often in relatively high doses, which may carry an excess of risk over unproven added benefit.
Biological PsychiatryNicotine exposure and tardive dyskinesia
121 Citations1987R. Yassa, Samarthji Lal +2 more
The present findings suggest that smoking is a risk factor for the development of tardive dyskinesia in chronic psychiatric outpatients and treatment with mecamylamine or other central nicotine antagonists merits investigation.
Biological PsychiatrySmoking and movement disorders in psychiatric patients
96 Citations1991Matthew Menza, Nancy Grossman +3 more
Patients with chronic psychiatric illnesses were blindly evaluated for tardive dyskinesia, neuroleptic-induced parkinsonism, and akathisia and patients who smoked received significantly higher doses of neuroleptics but did not have significantly more frequent or more severe tardives dyskine or parkinsonisms.
Archives of General PsychiatryThe Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics
93 Citations1991Linda Ganzini
Neuroleptic-treated diabetics had a significantly higher prevalence and severity of tardive dyskinesia, and it is suggested that diabetes mellitus should be examined further as a risk factor for tardiv dysKinesia.
Schizophrenia BulletinTreatment of Late-life Schizophrenia With Neuroleptics
91 Citations1993D. V. Jeste, Jonathan P. Lacro +3 more
If neuroleptics are withdrawn, there is a significant risk of a schizophrenic relapse; however, that risk is no greater in older patients than in younger ones, and clinical recommendations for the use of neuroleptic treatment are offered.
PsychopharmacologyTardive dyskinesia: Age and sex differences in hospitalized schizophrenics
83 Citations1978James M. Smith, William T. Oswald +2 more
An examination of the severity of tardive dyskinesia in psychiatric inpatients using the Abnormal Involuntary Movement Scale (AIMS) indicates differing trends with age for each sex, with females showing a significant linear increase with age, while males display a significant curvilinear relationship.
Comprehensive PsychiatryIncreased tardive dyskinesia in alcohol-abusing schizophrenic patients
80 Citations1992Lisa B. Dixon, Peter J. Weiden +3 more
In a consecutive admission of 75 hospitalized schizophrenics, drug or alcohol abusers had significantly higher TD scores than nonabusers and the association of alcohol abuse or dependence with TD seemed independent from other risk factors for TD.
Journal of Clinical PsychopharmacologyThe Natural History of Tardive Dyskinesia
80 Citations1988G. Gárdos, Jonathan Cole +4 more
A naturalistic study with pharmacotherapy tailored to the underlying psychiatric disorder and conducted long-term from TD onset is the ideal design for investigating the natural history of tardive dyskinesia.
American Journal of PsychiatryDiabetes and development of tardive dyskinesia
75 Citations1993Margaret G. Woerner, Bruce L. Saltz +3 more
The authors examined 160 elderly individuals who were beginning neuroleptic treatment; 24 had diabetes and 136 did not, and the cumulative incidence rates of tardive dyskinesia were 54.1% (SE = 5.6%) for the diabetics and 25.6% (SSE = 16.1) for the nondiabetics.
The American Journal of Drug and Alcohol AbuseTardive Dyskinesia in Psychiatric Patients with Substance Use Disorders
63 Citations1990Arturo A. On vera, Mary Mary. Kiefer +1 more
It is concluded that chronic use of alcohol by mental patients undergoing pharmacotherapy with neuroleptics enhances the vulnerability of these patients to tardive dyskinesia.
American Journal of PsychiatryChanging patterns of neuroleptic dosage over a decade
62 Citations1989Gerard T. Reardon, A Rifkin +3 more
A study of patterns of neuroleptic dosage for 206 schizophrenic inpatients showed significant differences over time and among three centers--a general hospital psychiatric unit, a community mental health center, and a state hospital.
Archives of Internal MedicineMetoclopramide-Induced Neuroleptic Malignant Syndrome
56 Citations1987Lawrence S. Friedman
Two diabetic patients at an institution who developed neuroleptic malignant syndrome in association with antiemetic metoclopramide hydrochloride are described.
Acta Psychiatrica ScandinavicaPersistent tardive dyskinesia: demographic and pharmacological risk factors
45 Citations1993G. Muscettola, G. Muscettola +6 more
The results support the view that both vulnerability factors and high neuroleptic doses contribute to the occurrence of TD and further stress the relevance of a conservative use of antipsychotic medication, particularly in older women.
American Journal of PsychiatryPharmaco-epidemiology in 136 hospitalized schizophrenic patients
44 Citations1987Julie M. Zito, Tom Craig +2 more
The authors surveyed pharmacotherapy in a group of 136 newly admitted patients with a DSM-III diagnosis of schizophrenia, and found no statistical association between length of stay and the mean daily dose of antipsychotic medication.
PubMedAffective disorders and tardive dyskinesia.
43 Citations1988Casey De
Evidence from multiple lines of study indicate that mood disorders, particularly depression, are a risk factor for developing tardive dyskinesia (TD), and neuroleptic drugs should be limited to managing acute psychotic symptoms in patients with mood disorders.
Biological PsychiatryClinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia
41 Citations1991Michael P. Caligiuri, James B. Lohr +2 more
It was found that tardive dyskinesia and tremor or rigidity did not lateralize to opposite limbs, thus weakening the hypothesis that TD and NIP stemmed from reciprocal pathophysiological mechanisms.
Journal of Clinical PsychopharmacologyEffects of Anticholinergic Agents on Patients with Tardive Dyskinesia and Concomitant Drug-Induced Parkinsonism
37 Citations1989William C. Wirshing, Donald L. Freidenberg +2 more
Observations indicate that electromechanical devices identify a subpopulation of TD patients who may acutely benefit from anticholinergic treatment.
Journal of NeuropsychiatryFine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand
34 Citations1990
Results indicated that spectral analysis of isometric posture represents a reliable, sensitive, and valid measure of neuroleptic-induced dyskinesia.
PubMedHigh incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
31 Citations1992Harris Mj, D Panton +4 more
Instrumental assessment showed that a greater proportion of TD patients had subclinical evidence of dyskinesia prior to the institution of neuroleptics, compared with non-TD patients.
NeurologyElectrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease
31 Citations1993Udo Kischka, Allen S. Mandir +2 more
Psychiatric ServicesPrevalence of Tardive Dyskinesia Among Three Ethnic Groups of Chronic Psychiatric Patients
29 Citations1991John J. Sramek, Swati Roy +4 more
A relationship was found between lower prevalence of tardive dyskinesia and higher current neuroleptic dosage, suggesting that higher dosage masks symptoms of tARDive dysKinesia.
Archives of General PsychiatryConsidering Neuroleptic Maintenance and Taper on a Continuum
25 Citations1995Dilip V. Jeste
While the authors know a lot more today about the pathophysiology of schizophrenia and other psychoses and about the mechanism of action of neuroleptic drugs than they did in 1960, there is yet much more that is unknown.
PubMedQuantitative instrumental measurement of tardive dyskinesia: a review.
22 Citations1992Lohr Jb, Caligiuri Mp
The advantages and disadvantages of the use of accelerometers, electromyography, force gauges, position transducers, and Doppler ultrasound from both a diagnostic and a utilitarian perspective are discussed.
General Hospital PsychiatryMetoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus
14 Citations1992Daniel D. Sewell, Blain H. Yoshinobu +2 more
Two case reports of hemodialysis patients who were treated with metoclopramide for diabetic gastroparesis, both patients developed persistent tardive dyskinesia within 12 months of beginning treatment.
Journal of GerontologyInstrumental Evidence That Age Increases Motor Instability in Neuroleptic-treated Patients
9 Citations1991Michael P. Caligiuri, J. B. Lohr +1 more
It is indicated that advanced age and neuroleptics exposure contributed to significantly greater motor instability than would be expected by advanced age or neuroleptic exposure alone.
Annals of Biomedical EngineeringClassification of resistance to passive motion using minimum probability of error criterion
2 Citations1987Henry C. B. Chan, M.T. Manry +1 more
A computerized technique is described for classifying a patient's condition as ‘Normal’ or ‘Parkinson disease’ (rigidity), from the torque versus angle curve for the knee joint, using a Legendre polynomial, fit to the curve.